Gary W. Pace's most recent trade in Cardiff Oncology Inc was a trade of 350,115 Common Stock done at an average price of $2.6 . Disclosure was reported to the exchange on Dec. 11, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cardiff Oncology Inc | Gary W. Pace | Director | Purchase of securities on an exchange or from another person at price $ 2.60 per share. | 11 Dec 2024 | 350,115 | 1,047,876 (10%) | 3% | 2.6 | 910,299 | Common Stock |
| Cardiff Oncology Inc | Gary W. Pace | Director | Purchase of securities on an exchange or from another person at price $ 2.60 per share. | 11 Dec 2024 | 11,500 | 1,059,376 (10%) | 0% | 2.6 | 29,900 | Common Stock |
| Cardiff Oncology Inc | Gary W. Pace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 29,700 | 146,974 | - | - | Stock Options | |
| Pacira BioSciences Inc | Gary W. Pace | Director | Sale of securities on an exchange or to another person at price $ 30.60 per share. | 06 Mar 2024 | 90,000 | 22,127 (0%) | 0% | 30.6 | 2,754,000 | Common Stock |
| Pacira BioSciences Inc | Gary W. Pace | Director | Sale of securities on an exchange or to another person at price $ 30.81 per share. | 06 Mar 2024 | 28,257 | 112,127 (0%) | 0% | 30.8 | 870,598 | Common Stock |
| Pacira BioSciences Inc | Gary W. Pace | Director | Sale of securities on an exchange or to another person at price $ 29.67 per share. | 06 Mar 2024 | 1,066 | 140,384 (0%) | 0% | 29.7 | 31,628 | Common Stock |
| Cardiff Oncology Inc | Pace Gary W. | Director | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 19 Dec 2023 | 30,000 | 697,761 (6%) | 0% | 1.4 | 41,100 | Common Stock |
| Cardiff Oncology Inc | Gary W. Pace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 27,700 | 117,274 | - | - | Stock Options | |
| Pacira BioSciences Inc | Gary W. Pace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,925 | 12,925 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Gary W. Pace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 1,775 | 141,450 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Gary W. Pace | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.90 per share. | 11 May 2023 | 7,000 | 144,690 (0%) | 0% | 29.9 | 209,300 | Common Stock |
| Pacira BioSciences Inc | Gary W. Pace | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 7,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Gary W. Pace | Director | Sale of securities on an exchange or to another person at price $ 41.78 per share. | 11 May 2023 | 5,015 | 139,675 (0%) | 0% | 41.8 | 209,527 | Common Stock |
| Cardiff Oncology Inc | Gary W. Pace | Director | Purchase of securities on an exchange or from another person at price $ 1.71 per share. | 15 Sep 2022 | 150,000 | 644,811 (6%) | 1% | 1.7 | 256,500 | Common Stock |
| Pacira BioSciences Inc | Gary W. Pace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 8,225 | 8,225 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Gary W. Pace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 1,160 | 137,690 (0%) | 0% | 0 | Common Stock | |
| Cardiff Oncology Inc | Gary W. Pace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 26,800 | 89,574 | - | - | Stock Options | |
| Pacira BioSciences Inc | Gary W. Pace | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 03 Mar 2022 | 7,000 | 136,530 (0%) | 0% | 10.8 | 75,670 | Common Stock |
| Pacira BioSciences Inc | Gary W. Pace | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2022 | 7,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Gary W. Pace | Director | Sale of securities on an exchange or to another person at price $ 66.83 per share. | 28 Feb 2022 | 28,641 | 129,530 (0%) | 0% | 66.8 | 1,914,078 | Common Stock |
| Pacira BioSciences Inc | Gary W. Pace | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 18,834 | 1,166 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Gary W. Pace | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.02 per share. | 28 Feb 2022 | 18,834 | 158,171 (0%) | 0% | 11.0 | 207,551 | Common Stock |
| Pacira BioSciences Inc | Gary W. Pace | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 9,807 | 193 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Gary W. Pace | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.02 per share. | 28 Feb 2022 | 9,807 | 139,337 (0%) | 0% | 11.0 | 108,073 | Common Stock |
| Pacira BioSciences Inc | Gary W. Pace | Director | Sale of securities on an exchange or to another person at price $ 67.75 per share. | 28 Feb 2022 | 1,359 | 129,530 (0%) | 0% | 67.7 | 92,072 | Common Stock |
| Pacira BioSciences Inc | Gary W. Pace | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 1,166 | 0 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Gary W. Pace | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.02 per share. | 28 Feb 2022 | 1,166 | 130,889 (0%) | 0% | 11.0 | 12,849 | Common Stock |
| Pacira BioSciences Inc | Gary W. Pace | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 193 | 0 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Gary W. Pace | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.02 per share. | 28 Feb 2022 | 193 | 129,723 (0%) | 0% | 11.0 | 2,127 | Common Stock |
| Cardiff Oncology Inc | Gary W. Pace | Director | Purchase of securities on an exchange or from another person at price $ 6.75 per share. | 21 Sep 2021 | 30,000 | 494,811 (4%) | 0% | 6.8 | 202,500 | Common Stock |
| Cardiff Oncology Inc | Gary W. Pace | Director | Purchase of securities on an exchange or from another person at price $ 10.20 per share. | 23 Mar 2021 | 5,000 | 459,811 (4%) | 0% | 10.2 | 51,000 | Common Stock |
| Cardiff Oncology Inc | Gary W. Pace | Director | Purchase of securities on an exchange or from another person at price $ 10.31 per share. | 23 Mar 2021 | 2,500 | 464,811 (4%) | 0% | 10.3 | 25,775 | Common Stock |
| Cardiff Oncology Inc | Gary W. Pace | Director | Purchase of securities on an exchange or from another person at price $ 10.21 per share. | 23 Mar 2021 | 2,500 | 462,311 (4%) | 0% | 10.2 | 25,525 | Common Stock |
| Cardiff Oncology Inc | Gary W. Pace | Director | Purchase of securities on an exchange or from another person at price $ 10.54 per share. | 18 Mar 2021 | 2,000 | 454,811 (4%) | 0% | 10.5 | 21,080 | Common Stock |
| Cardiff Oncology Inc | Gary W. Pace | Director | Purchase of securities on an exchange or from another person at price $ 10.58 per share. | 18 Mar 2021 | 1,000 | 452,811 (4%) | 0% | 10.6 | 10,580 | Common Stock |
| Cardiff Oncology Inc | Gary W. Pace | Director | Purchase of securities on an exchange or from another person at price $ 9.27 per share. | 04 Mar 2021 | 1,500 | 451,811 (4%) | 0% | 9.3 | 13,898 | Common Stock |
| Pacira BioSciences Inc | Gary W. Pace | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2020 | 70,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Gary W. Pace | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.67 per share. | 25 Sep 2020 | 70,000 | 129,949 (0%) | 0% | 16.7 | 1,166,900 | Common Stock |
| Cardiff Oncology Inc | Gary W. Pace | Director | Purchase of securities on an exchange or from another person at price $ 5.69 per share. | 16 Sep 2020 | 1,700 | 449,461 (4%) | 0% | 5.7 | 9,673 | Common Stock |
| Cardiff Oncology Inc | Gary W. Pace | Director | Purchase of securities on an exchange or from another person at price $ 5.71 per share. | 16 Sep 2020 | 850 | 450,311 (4%) | 0% | 5.7 | 4,854 | Common Stock |